Cognitive, anxiety and depressive disorders in middelage subjects with metabolic syndrome are associated with elevated endocannabinoid plasma level

Obesity and metabolic syndrome (MS) are associated with an increased risk of developing psychiatric disorders, such as mood disorders and cognitive disorders. Endocannabinoids (EC) are neuromodulators which are involved in a plenty of physiological processes: regulation of motor activity, neuroprote...

Full description

Saved in:
Bibliographic Details
Published inEuropean psychiatry Vol. 33; p. S155
Main Authors Piotrovskaya, V., Neznanov, N.
Format Journal Article
LanguageEnglish
Published Elsevier Masson SAS 01.03.2016
Subjects
Internal Medicine
Psychiatry
Online AccessGet full text
ISSN0924-9338
1778-3585
DOI10.1016/j.eurpsy.2016.01.233

Cover